200 related articles for article (PubMed ID: 36060673)
41. A comprehensive evaluation of progestin-primed ovarian stimulation protocol in patients with or without PCOS undergoing in vitro fertilization.
Zhu J; Zhang J; Yang J; Li D; Wang C; Elizur SE; Zhao K; Kuang Y; Wang Y
Reprod Biol; 2021 Dec; 21(4):100540. PubMed ID: 34416405
[TBL] [Abstract][Full Text] [Related]
42. Comparison of euploidy rates of blastocysts in women treated with progestins or GnRH antagonist to prevent the luteinizing hormone surge during ovarian stimulation.
La Marca A; Capuzzo M; Sacchi S; Imbrogno MG; Spinella F; Varricchio MT; Minasi MG; Greco P; Fiorentino F; Greco E
Hum Reprod; 2020 Jun; 35(6):1325-1331. PubMed ID: 32395749
[TBL] [Abstract][Full Text] [Related]
43. Evaluation of Ovarian Stimulation Initiated From the Late Follicular Phase Using Human Menopausal Gonadotropin Alone in Normal-Ovulatory Women for Treatment of Infertility: A Retrospective Cohort Study.
Zhu X; Fu Y
Front Endocrinol (Lausanne); 2019; 10():448. PubMed ID: 31333588
[No Abstract] [Full Text] [Related]
44. In-vitro maturation of oocytes vs in-vitro fertilization with a gonadotropin-releasing hormone antagonist for women with polycystic ovarian syndrome: can superiority be defined?
Shavit T; Ellenbogen A; Michaeli M; Kartchovsky E; Ruzov O; Shalom-Paz E
Eur J Obstet Gynecol Reprod Biol; 2014 Aug; 179():46-50. PubMed ID: 24965979
[TBL] [Abstract][Full Text] [Related]
45. Duphaston and human menopausal gonadotropin protocol in normally ovulatory women undergoing controlled ovarian hyperstimulation during in vitro fertilization/intracytoplasmic sperm injection treatments in combination with embryo cryopreservation.
Zhu X; Ye H; Fu Y
Fertil Steril; 2017 Sep; 108(3):505-512.e2. PubMed ID: 28697910
[TBL] [Abstract][Full Text] [Related]
46. Controlled ovulation of the dominant follicle using progestin in minimal stimulation in poor responders.
Chen Q; Wang Y; Sun L; Zhang S; Chai W; Hong Q; Long H; Wang L; Lyu Q; Kuang Y
Reprod Biol Endocrinol; 2017 Sep; 15(1):71. PubMed ID: 28870217
[TBL] [Abstract][Full Text] [Related]
47. Elevated basal luteinizing hormone does not impair the outcome of human menopausal gonadotropin and medroxyprogesterone acetate treatment cycles.
Sun L; Ye J; Wang Y; Chen Q; Cai R; Fu Y; Tian H; Lyu Q; Lu X; Kuang Y
Sci Rep; 2018 Sep; 8(1):13835. PubMed ID: 30217999
[TBL] [Abstract][Full Text] [Related]
48. Utrogestan as an effective oral alternative for preventing premature luteinizing hormone surges in women undergoing controlled ovarian hyperstimulation for in vitro fertilization.
Zhu X; Zhang X; Fu Y
Medicine (Baltimore); 2015 May; 94(21):e909. PubMed ID: 26020402
[TBL] [Abstract][Full Text] [Related]
49. Dydrogesterone-primed ovarian stimulation is an effective alternative to gonadotropin-releasing hormone antagonist protocol for freeze-all cycles in polycystic ovary syndrome.
Gurbuz AS; Gode F
J Obstet Gynaecol Res; 2020 Aug; 46(8):1403-1411. PubMed ID: 32500628
[TBL] [Abstract][Full Text] [Related]
50. A randomized comparison of two ovarian stimulation protocols with gonadotropin-releasing hormone (GnRH) antagonist cotreatment for in vitro fertilization commencing recombinant follicle-stimulating hormone on cycle day 2 or 5 with the standard long GnRH agonist protocol.
Hohmann FP; Macklon NS; Fauser BC
J Clin Endocrinol Metab; 2003 Jan; 88(1):166-73. PubMed ID: 12519847
[TBL] [Abstract][Full Text] [Related]
51. Medroxyprogesterone acetate is an effective oral alternative for preventing premature luteinizing hormone surges in women undergoing controlled ovarian hyperstimulation for in vitro fertilization.
Kuang Y; Chen Q; Fu Y; Wang Y; Hong Q; Lyu Q; Ai A; Shoham Z
Fertil Steril; 2015 Jul; 104(1):62-70.e3. PubMed ID: 25956370
[TBL] [Abstract][Full Text] [Related]
52. Randomized, Controlled Pilot Study of Low-Dose Human Chorionic Gonadotropin Administration Beginning From the Early Follicular Phase for Women With Polycystic Ovarian Syndrome Undergoing Ovarian Stimulation Using the Progesterone Protocol.
Zhu X; Fu Y
Front Endocrinol (Lausanne); 2019; 10():875. PubMed ID: 31920984
[No Abstract] [Full Text] [Related]
53. Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment.
Beckers NG; Macklon NS; Eijkemans MJ; Ludwig M; Felberbaum RE; Diedrich K; Bustion S; Loumaye E; Fauser BC
J Clin Endocrinol Metab; 2003 Sep; 88(9):4186-92. PubMed ID: 12970285
[TBL] [Abstract][Full Text] [Related]
54. Effect of Progestin-primed Ovarian Stimulation Protocol on Outcomes of Aged Infertile Women Who Failed to Get Pregnant in the First IVF/ ICSI Cycle: A Self-controlled Study.
Chen YM; Qi QR; Xie QZ; Yang YF; Xia Y; Zhou XD
Curr Med Sci; 2018 Jun; 38(3):513-518. PubMed ID: 30074220
[TBL] [Abstract][Full Text] [Related]
55. Medroxyprogesterone acetate versus ganirelix in oocyte donation: a randomized controlled trial.
Beguería R; García D; Vassena R; Rodríguez A
Hum Reprod; 2019 May; 34(5):872-880. PubMed ID: 30927417
[TBL] [Abstract][Full Text] [Related]
56. A Comparison of Outcomes from
Bleau N; Agdi M; Son W; Tan S; Dahan MH
Int J Fertil Steril; 2017; 11(2):79-84. PubMed ID: 28670424
[TBL] [Abstract][Full Text] [Related]
57. [Medroxyprogesteron acetate use to block LH surge in oocyte donor stimulation].
Crha I; Ventruba P; Filipinská E; Dziakova M; Žáková J; Ješeta M; Lousová E; Papíková Z
Ceska Gynekol; 2018; 83(1):11-16. PubMed ID: 29510633
[TBL] [Abstract][Full Text] [Related]
58. Effectiveness of the flexible progestin primed ovarian stimulation protocol compared to the flexible GnRH antagonist protocol in women with decreased ovarian reserve.
Turkgeldi E; Yildiz S; Cekic SG; Shakerian B; Keles I; Ata B
Hum Fertil (Camb); 2022 Apr; 25(2):306-312. PubMed ID: 32672129
[TBL] [Abstract][Full Text] [Related]
59. Gonadotropin-releasing hormone antagonist versus progestin for the prevention of premature luteinising hormone surges in poor responders undergoing in vitro fertilisation treatment: study protocol for a randomised controlled trial.
Wang Y; Kuang Y; Chen Q; Cai R
Trials; 2018 Aug; 19(1):455. PubMed ID: 30134964
[TBL] [Abstract][Full Text] [Related]
60. Repeat Dose of Gonadotropin-releasing Hormone Agonist Trigger in Polycystic Ovarian Syndrome Undergoing
Deepika K; Baiju P; Gautham P; Suvarna R; Arveen V; Kamini R
J Hum Reprod Sci; 2017; 10(4):271-280. PubMed ID: 29430154
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
